ClinicalTrials.govpublic full text
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
multiple myeloma, adoptive t cell therapy, chimeric antigen receptor, 18-367, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1046688
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.